AHSG and metabolic dysfunction-associated steatotic liver disease: NAFLD proportion presented a significant difference among the three groups (P < 0.001) that the prevalence rate of NAFLD decreased (75 %, 40 %, and 36 %), as Fetuin A level elevated (Figure 3).